The company
Pliant Therapeutics, Inc.
PLRX · Nasdaq
PLRX stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 46 weeks. It is 22.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 46
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $327K
- Officials’ trades on record
- 0
- Institutions holding
- 82 (-1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Minnie KuoChief Operating Officer | sold | 6,917at $1.28 | 20 Jan 2026filed 22 Jan 2026 |
| Bernard CouliePresident and CEO | sold | 89,375at $1.28 | 20 Jan 2026filed 22 Jan 2026 |
| Lily CheungChief Human Resource Officer | sold | 7,534at $1.28 | 20 Jan 2026filed 22 Jan 2026 |
| Keith Lamont CummingsChief Financial Officer | sold | 24,002at $1.28 | 20 Jan 2026filed 22 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| TANG CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026 | 6,141,261$7.0M | -1,8710.0% |
| ADAR1 Capital Management, LLCadded · filed 14 Aug 2026 | 5,509,724$6.3M | +2,924,598+113.1% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,440,351$2.8M | +97,250+4.2% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 2,262,832$2.6M | +9,694+0.4% |
| CITADEL ADVISORS LLCreduced · filed 14 Aug 2026 | 2,142,226$2.4M | -1,084,373−33.6% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 2,049,874$2.3M | +197,032+10.6% |
| Monaco Asset Management SAMunchanged · filed 7 Aug 2026 | 1,938,747$2.2M | 00.0% |
| Lynx1 Capital Management LPnew · filed 12 Aug 2026 | 1,798,070$2.0M | +1,798,070 |
| BML Capital Management, LLCunchanged · filed 7 Aug 2026 | 1,546,137$1.8M | 00.0% |
| Prosight Management, LPreduced · filed 14 Aug 2026 | 1,370,233$1.6M | -297,367−17.8% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.